APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urinary Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Urinary Drugs Industry Growth and Trends Forecast to 2032

20 December 202598 pages

Choose your research edition.

Industry ResearchUrinary Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Urinary Drugs Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Urinary Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urinary Drugs Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Urinary Drugs Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Urinary Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Urinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Urinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Urinary Drugs include Sanofi S.A., Pfizer Inc., GlaxosmithKline Plc., Bayer AG, Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Company Limited, Astellas Pharma Inc. and Allergan Plc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Urinary Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Urinary Drugs market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Urinary Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Urinary Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Urinary Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Urinary Drugs Market by Company

Sanofi S.A.

Pfizer Inc.

GlaxosmithKline Plc.

Bayer AG

Otsuka Pharmaceutical Co., Ltd.

Daiichi Sankyo Company Limited

Astellas Pharma Inc.

Allergan Plc.

Urinary Drugs Segment by Type

Oral

Injectables

Urinary Drugs Segment by Application

Clinic

Hospital

Home Care

Urinary Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urinary Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urinary Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urinary Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Urinary Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Urinary Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injectables Table 3. Global Urinary Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 5. Global Urinary Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Urinary Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Urinary Drugs Price by Type (2021-2026) & (US$/ton) Table 9. Global Urinary Drugs Sales by Type (2027-2032) & (k tons) Table 10. Global Urinary Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Urinary Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Urinary Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Urinary Drugs Price by Type (2027-2032) & (US$/ton) Table 14. North America Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 15. North America Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 17. Europe Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 19. Asia-Pacific Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 21. Latin America Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Urinary Drugs Sales by Type (2021-2026) & (k tons) Table 23. Middle East and Africa Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Urinary Drugs Industry Trends Table 25. Urinary Drugs Industry Drivers Table 26. Urinary Drugs Industry Opportunities and Challenges Table 27. Urinary Drugs Industry Restraints Table 28. Global Urinary Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Urinary Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Urinary Drugs Sales by Company (2021-2026) & (k tons) Table 31. Global Urinary Drugs Sales Share by Company (2021-2026) Table 32. Global Urinary Drugs Market Price by Company (2021-2026) & (US$/ton) Table 33. Global Urinary Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Urinary Drugs Major Company Production Sites and Headquarters Table 35. Global Urinary Drugs Company, Product Type & Application Table 36. Global Urinary Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Urinary Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Urinary Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Urinary Drugs Sales by Region (2021-2026) & (k tons) Table 41. Global Urinary Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Urinary Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Urinary Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Urinary Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 45. Global Urinary Drugs Sales by Region (2027-2032) & (k tons) Table 46. Global Urinary Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Urinary Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Urinary Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Urinary Drugs Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 50. Global Urinary Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 52. Global Urinary Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Urinary Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Urinary Drugs Price by Application (2021-2026) & (US$/ton) Table 56. Global Urinary Drugs Sales by Application (2027-2032) & (k tons) Table 57. Global Urinary Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Urinary Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Urinary Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Urinary Drugs Price by Application (2027-2032) & (US$/ton) Table 61. North America Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 62. North America Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 64. Europe Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 66. Asia-Pacific Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 68. Latin America Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Urinary Drugs Sales by Application (2021-2026) & (k tons) Table 70. Middle East and Africa Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi S.A. Company Information Table 72. Sanofi S.A. Business Overview Table 73. Sanofi S.A. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 74. Sanofi S.A. Urinary Drugs Product Portfolio Table 75. Sanofi S.A. Recent Development Table 76. Pfizer Inc. Company Information Table 77. Pfizer Inc. Business Overview Table 78. Pfizer Inc. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 79. Pfizer Inc. Urinary Drugs Product Portfolio Table 80. Pfizer Inc. Recent Development Table 81. GlaxosmithKline Plc. Company Information Table 82. GlaxosmithKline Plc. Business Overview Table 83. GlaxosmithKline Plc. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 84. GlaxosmithKline Plc. Urinary Drugs Product Portfolio Table 85. GlaxosmithKline Plc. Recent Development Table 86. Bayer AG Company Information Table 87. Bayer AG Business Overview Table 88. Bayer AG Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 89. Bayer AG Urinary Drugs Product Portfolio Table 90. Bayer AG Recent Development Table 91. Otsuka Pharmaceutical Co., Ltd. Company Information Table 92. Otsuka Pharmaceutical Co., Ltd. Business Overview Table 93. Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 94. Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Product Portfolio Table 95. Otsuka Pharmaceutical Co., Ltd. Recent Development Table 96. Daiichi Sankyo Company Limited Company Information Table 97. Daiichi Sankyo Company Limited Business Overview Table 98. Daiichi Sankyo Company Limited Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 99. Daiichi Sankyo Company Limited Urinary Drugs Product Portfolio Table 100. Daiichi Sankyo Company Limited Recent Development Table 101. Astellas Pharma Inc. Company Information Table 102. Astellas Pharma Inc. Business Overview Table 103. Astellas Pharma Inc. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 104. Astellas Pharma Inc. Urinary Drugs Product Portfolio Table 105. Astellas Pharma Inc. Recent Development Table 106. Allergan Plc. Company Information Table 107. Allergan Plc. Business Overview Table 108. Allergan Plc. Urinary Drugs Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 109. Allergan Plc. Urinary Drugs Product Portfolio Table 110. Allergan Plc. Recent Development Table 111. North America Urinary Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 112. North America Urinary Drugs Sales by Country (2021-2026) & (k tons) Table 113. North America Urinary Drugs Sales Market Share by Country (2021-2026) Table 114. North America Urinary Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 115. North America Urinary Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. North America Urinary Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Urinary Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Urinary Drugs Market Share by Country (2021-2026) Table 119. North America Urinary Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Urinary Drugs Market Share Forecast by Country (2027-2032) Table 121. Europe Urinary Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 122. Europe Urinary Drugs Sales by Country (2021-2026) & (k tons) Table 123. Europe Urinary Drugs Sales Market Share by Country (2021-2026) Table 124. Europe Urinary Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 125. Europe Urinary Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Urinary Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Urinary Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Urinary Drugs Market Share by Country (2021-2026) Table 129. Europe Urinary Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Urinary Drugs Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Urinary Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Urinary Drugs Sales by Country (2021-2026) & (k tons) Table 133. Asia-Pacific Urinary Drugs Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Urinary Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 135. Asia-Pacific Urinary Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Urinary Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Urinary Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Urinary Drugs Market Share by Country (2021-2026) Table 139. Asia-Pacific Urinary Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Urinary Drugs Market Share Forecast by Country (2027-2032) Table 141. Latin America Urinary Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 142. Latin America Urinary Drugs Sales by Country (2021-2026) & (k tons) Table 143. Latin America Urinary Drugs Sales Market Share by Country (2021-2026) Table 144. Latin America Urinary Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 145. Latin America Urinary Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Urinary Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Urinary Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Urinary Drugs Market Share by Country (2021-2026) Table 149. Latin America Urinary Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Urinary Drugs Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Urinary Drugs Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Urinary Drugs Sales by Country (2021-2026) & (k tons) Table 153. Middle East and Africa Urinary Drugs Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Urinary Drugs Sales Forecast by Country (2027-2032) & (k tons) Table 155. Middle East and Africa Urinary Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Urinary Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Urinary Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Urinary Drugs Market Share by Country (2021-2026) Table 159. Middle East and Africa Urinary Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Urinary Drugs Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Urinary Drugs Distributors List Table 164. Urinary Drugs Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Urinary Drugs Image Figure 2. Global Urinary Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urinary Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Urinary Drugs Sales (2021-2032) & (k tons) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (k tons) Figure 7. Injectables Image Figure 8. Global Injectables Sales YoY Growth (2021-2032) & (k tons) Figure 9. Global Urinary Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Urinary Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Urinary Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Urinary Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Urinary Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Urinary Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Urinary Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Urinary Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Urinary Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Urinary Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Urinary Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Urinary Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Urinary Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinic Image Figure 24. Global Clinic Sales YoY Growth (2021-2032) & (k tons) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k tons) Figure 27. Home Care Image Figure 28. Global Home Care Sales YoY Growth (2021-2032) & (k tons) Figure 29. Global Urinary Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Urinary Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Urinary Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Urinary Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Urinary Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Urinary Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Urinary Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Urinary Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Urinary Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Urinary Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Urinary Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Urinary Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 42. North America Urinary Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Urinary Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Urinary Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 46. Europe Urinary Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Urinary Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Urinary Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 50. Asia-Pacific Urinary Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Urinary Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Urinary Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 54. Latin America Urinary Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Urinary Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Urinary Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 58. Middle East and Africa Urinary Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Urinary Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Urinary Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Urinary Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Urinary Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injectables
Applications
  • Clinic
  • Hospital
  • Home Care
Companies covered
  • Sanofi S.A.
  • Pfizer Inc.
  • GlaxosmithKline Plc.
  • Bayer AG
  • Otsuka Pharmaceutical Co., Ltd.
  • Daiichi Sankyo Company Limited
  • Astellas Pharma Inc.
  • Allergan Plc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Urinary Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Urinary Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Urinary Drugs Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injectables
  8. 1.4 Global Urinary Drugs Market Size by Type
  9. 1.4.1 Global Urinary Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Urinary Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Urinary Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Urinary Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Urinary Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Urinary Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Urinary Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Urinary Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Urinary Drugs Industry Trends
  2. 2.2 Urinary Drugs Industry Drivers
  3. 2.3 Urinary Drugs Industry Opportunities and Challenges
  4. 2.4 Urinary Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Urinary Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Urinary Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Urinary Drugs Price (2021-2026)
  4. 3.4 Global Urinary Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Urinary Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Urinary Drugs Company, Product Type & Application
  7. 3.7 Global Urinary Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Urinary Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Urinary Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Urinary Drugs Tier 1, Tier 2, and Tier 3
4 Urinary Drugs Regional Status and Outlook
  1. 4.1 Global Urinary Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Urinary Drugs Historic Market Size by Region
  3. 4.2.1 Global Urinary Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Urinary Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Urinary Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Urinary Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Urinary Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Urinary Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Urinary Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Urinary Drugs by Application
  1. 5.1 Urinary Drugs Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Home Care
  5. 5.2 Global Urinary Drugs Market Size by Application
  6. 5.2.1 Global Urinary Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Urinary Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Urinary Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Urinary Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Urinary Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Urinary Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Urinary Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Urinary Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi S.A.
  2. 6.1.1 Sanofi S.A. Company Information
  3. 6.1.2 Sanofi S.A. Business Overview
  4. 6.1.3 Sanofi S.A. Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi S.A. Urinary Drugs Product Portfolio
  6. 6.1.5 Sanofi S.A. Recent Developments
  7. 6.2 Pfizer Inc.
  8. 6.2.1 Pfizer Inc. Company Information
  9. 6.2.2 Pfizer Inc. Business Overview
  10. 6.2.3 Pfizer Inc. Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Inc. Urinary Drugs Product Portfolio
  12. 6.2.5 Pfizer Inc. Recent Developments
  13. 6.3 GlaxosmithKline Plc.
  14. 6.3.1 GlaxosmithKline Plc. Company Information
  15. 6.3.2 GlaxosmithKline Plc. Business Overview
  16. 6.3.3 GlaxosmithKline Plc. Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GlaxosmithKline Plc. Urinary Drugs Product Portfolio
  18. 6.3.5 GlaxosmithKline Plc. Recent Developments
  19. 6.4 Bayer AG
  20. 6.4.1 Bayer AG Company Information
  21. 6.4.2 Bayer AG Business Overview
  22. 6.4.3 Bayer AG Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer AG Urinary Drugs Product Portfolio
  24. 6.4.5 Bayer AG Recent Developments
  25. 6.5 Otsuka Pharmaceutical Co., Ltd.
  26. 6.5.1 Otsuka Pharmaceutical Co., Ltd. Company Information
  27. 6.5.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
  28. 6.5.3 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Otsuka Pharmaceutical Co., Ltd. Urinary Drugs Product Portfolio
  30. 6.5.5 Otsuka Pharmaceutical Co., Ltd. Recent Developments
  31. 6.6 Daiichi Sankyo Company Limited
  32. 6.6.1 Daiichi Sankyo Company Limited Company Information
  33. 6.6.2 Daiichi Sankyo Company Limited Business Overview
  34. 6.6.3 Daiichi Sankyo Company Limited Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Daiichi Sankyo Company Limited Urinary Drugs Product Portfolio
  36. 6.6.5 Daiichi Sankyo Company Limited Recent Developments
  37. 6.7 Astellas Pharma Inc.
  38. 6.7.1 Astellas Pharma Inc. Company Information
  39. 6.7.2 Astellas Pharma Inc. Business Overview
  40. 6.7.3 Astellas Pharma Inc. Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Astellas Pharma Inc. Urinary Drugs Product Portfolio
  42. 6.7.5 Astellas Pharma Inc. Recent Developments
  43. 6.8 Allergan Plc.
  44. 6.8.1 Allergan Plc. Company Information
  45. 6.8.2 Allergan Plc. Business Overview
  46. 6.8.3 Allergan Plc. Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Allergan Plc. Urinary Drugs Product Portfolio
  48. 6.8.5 Allergan Plc. Recent Developments
7 North America by Country
  1. 7.1 North America Urinary Drugs Sales by Country
  2. 7.1.1 North America Urinary Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Urinary Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Urinary Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Urinary Drugs Market Size by Country
  6. 7.2.1 North America Urinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Urinary Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Urinary Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Urinary Drugs Sales by Country
  2. 8.1.1 Europe Urinary Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Urinary Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Urinary Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Urinary Drugs Market Size by Country
  6. 8.2.1 Europe Urinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Urinary Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Urinary Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Urinary Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Urinary Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Urinary Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Urinary Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Urinary Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Urinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Urinary Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Urinary Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Urinary Drugs Sales by Country
  2. 10.1.1 South America Urinary Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Urinary Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Urinary Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Urinary Drugs Market Size by Country
  6. 10.2.1 South America Urinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Urinary Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Urinary Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Urinary Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Urinary Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Urinary Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Urinary Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Urinary Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Urinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Urinary Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Urinary Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Urinary Drugs Value Chain Analysis
  2. 12.1.1 Urinary Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Urinary Drugs Production Mode & Process
  7. 12.2 Urinary Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Urinary Drugs Distributors
  10. 12.2.3 Urinary Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst